99 related articles for article (PubMed ID: 10395747)
21. Purification and use of E. coli peptide deformylase for peptide deprotection in chemoenzymatic peptide synthesis.
Di Toma C; Sonke T; Quaedflieg PJ; Volker Wagner AF; Janssen DB
Protein Expr Purif; 2013 May; 89(1):73-9. PubMed ID: 23357810
[TBL] [Abstract][Full Text] [Related]
22. Phylogenomic and biochemical characterization of three Legionella pneumophila polypeptide deformylases.
Huang J; Van Aller GS; Taylor AN; Kerrigan JJ; Liu WS; Trulli JM; Lai Z; Holmes D; Aubart KM; Brown JR; Zalacain M
J Bacteriol; 2006 Jul; 188(14):5249-57. PubMed ID: 16816197
[TBL] [Abstract][Full Text] [Related]
23. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
[TBL] [Abstract][Full Text] [Related]
24. Identification of a potent peptide deformylase inhibitor from a rationally designed combinatorial library.
Wei Y; Yi T; Huntington KM; Chaudhury C; Pei D
J Comb Chem; 2000; 2(6):650-7. PubMed ID: 11126293
[TBL] [Abstract][Full Text] [Related]
25. Novel approaches to antimicrobial therapy: peptide deformylase.
Waller AS; Clements JM
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):785-92. PubMed ID: 12630299
[TBL] [Abstract][Full Text] [Related]
26. Enzymatic properties of Escherichia coli peptide deformylase.
Meinnel T; Blanquet S
J Bacteriol; 1995 Apr; 177(7):1883-7. PubMed ID: 7896716
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for the design of antibiotics targeting peptide deformylase.
Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
[TBL] [Abstract][Full Text] [Related]
28. Structure analysis of peptide deformylases from Streptococcus pneumoniae, Staphylococcus aureus, Thermotoga maritima and Pseudomonas aeruginosa: snapshots of the oxygen sensitivity of peptide deformylase.
Kreusch A; Spraggon G; Lee CC; Klock H; McMullan D; Ng K; Shin T; Vincent J; Warner I; Ericson C; Lesley SA
J Mol Biol; 2003 Jul; 330(2):309-21. PubMed ID: 12823970
[TBL] [Abstract][Full Text] [Related]
29. [Peptide-deformylase inhibitors, a new class of antibiotics].
Dubreuil L
Presse Med; 2002 Nov; 31(38):1810-2. PubMed ID: 12497724
[TBL] [Abstract][Full Text] [Related]
30. Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biological activities and X-ray structures of oxazole hydroxamate-EcMetAP-Mn complexes.
Huguet F; Melet A; Alves de Sousa R; Lieutaud A; Chevalier J; Maigre L; Deschamps P; Tomas A; Leulliot N; Pages JM; Artaud I
ChemMedChem; 2012 Jun; 7(6):1020-30. PubMed ID: 22489069
[TBL] [Abstract][Full Text] [Related]
31. Understanding the highly efficient catalysis of prokaryotic peptide deformylases by shedding light on the determinants specifying the low activity of the human counterpart.
Fieulaine S; Desmadril M; Meinnel T; Giglione C
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):242-52. PubMed ID: 24531459
[TBL] [Abstract][Full Text] [Related]
32. 2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents.
Gupta MK; Mishra P; Prathipati P; Saxena AK
Bioorg Med Chem; 2002 Dec; 10(12):3713-6. PubMed ID: 12413827
[TBL] [Abstract][Full Text] [Related]
33. Eukaryotic peptide deformylases. Nuclear-encoded and chloroplast-targeted enzymes in Arabidopsis.
Dirk LM; Williams MA; Houtz RL
Plant Physiol; 2001 Sep; 127(1):97-107. PubMed ID: 11553738
[TBL] [Abstract][Full Text] [Related]
34. N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.
Hackbarth CJ; Chen DZ; Lewis JG; Clark K; Mangold JB; Cramer JA; Margolis PS; Wang W; Koehn J; Wu C; Lopez S; Withers G; Gu H; Dunn E; Kulathila R; Pan SH; Porter WL; Jacobs J; Trias J; Patel DV; Weidmann B; White RJ; Yuan Z
Antimicrob Agents Chemother; 2002 Sep; 46(9):2752-64. PubMed ID: 12183225
[TBL] [Abstract][Full Text] [Related]
35. Continuous spectrophotometric assay of peptide deformylase.
Wei Y; Pei D
Anal Biochem; 1997 Jul; 250(1):29-34. PubMed ID: 9234895
[TBL] [Abstract][Full Text] [Related]
36. H-phosphonate derivatives as novel peptide deformylase inhibitors.
Hu YJ; Rajagopalan PT; Pei D
Bioorg Med Chem Lett; 1998 Sep; 8(18):2479-82. PubMed ID: 9873565
[TBL] [Abstract][Full Text] [Related]
37. Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis.
Yoo JS; Zheng CJ; Lee S; Kwak JH; Kim WG
Bioorg Med Chem Lett; 2006 Sep; 16(18):4889-92. PubMed ID: 16809037
[TBL] [Abstract][Full Text] [Related]
38. Mapping the surface of Escherichia coli peptide deformylase by NMR with organic solvents.
Byerly DW; McElroy CA; Foster MP
Protein Sci; 2002 Jul; 11(7):1850-3. PubMed ID: 12070337
[TBL] [Abstract][Full Text] [Related]
39. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing.
Bingel-Erlenmeyer R; Kohler R; Kramer G; Sandikci A; Antolić S; Maier T; Schaffitzel C; Wiedmann B; Bukau B; Ban N
Nature; 2008 Mar; 452(7183):108-11. PubMed ID: 18288106
[TBL] [Abstract][Full Text] [Related]
40. Structures of E. coli peptide deformylase bound to formate: insight into the preference for Fe2+ over Zn2+ as the active site metal.
Jain R; Hao B; Liu RP; Chan MK
J Am Chem Soc; 2005 Apr; 127(13):4558-9. PubMed ID: 15796505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
